1天前
Telix Reports Third Quarter 2026 Financial Performance
**media[1269247]**MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix') provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026).Q3 2026 Highlights[1]Group revenue of US$245 million increased 19% over the prior corresponding quarter (Q3 2025) driven by continued strong demand for the commercial portfolio, in line with expectations. September sales drov
1天前
1天前
Weatherford Announces Third Quarter 2026 Results
Third quarter revenue of $1,143 million increased 3% sequentiallyThird quarter operating income of $153 million increased 43% sequentiallyThird quarter net income of $120 million increased 208% sequentially; net income margin of 10.5%Third quarter adjusted EBITDA* of $254 million increased 14% sequentially; adjusted EBITDA margin* of 22.2% increased 204 basis points sequentiallyThird quarter cash provided by operating activities of $192 million and adjusted free cash flow* of $155 millionShareho
1天前